/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Juan Antonio Virizuela

Hospital Universitario Virgen Macarena(ES)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

113

Papers

1.8K

Citations

18

h-index

33

i10-index

Juan Antonio Virizuela is an academic researcher from Hospital Universitario Virgen Macarena. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Cancer Treatment and Pharmacology. The author has an h-index of 18, co-authored 97 publications.

Research Topics

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Cancer Treatment and Pharmacology Advanced Breast Cancer Therapies Cancer Immunotherapy and Biomarkers

Papers by this author

works

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial

2019 · The Lancet Oncology · 194 citations

https://doi.org/10.1016/s1470-2045(19)30786-7

Aleix Prat Cristina Saura Tomás Pascual Cristina Hernándo

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

2017 · The Lancet Oncology · 120 citations

https://doi.org/10.1016/s1470-2045(17)30715-5

Marco Colleoni Weixiu Luo Per Karlsson Jacquie Chirgwin

SEOM clinical guidelines on nutrition in cancer patients (2018)

2019 · Clinical & Translational Oncology · 110 citations

https://doi.org/10.1007/s12094-018-02009-3

R. de las Peñas Margarita Majem Javier Pérez-Altozano Juan Antonio Virizuela

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial

2019 · BMC Medicine · 35 citations

https://doi.org/10.1186/s12916-018-1233-1

Joaquín Gavilá Mafalda Oliveira Tomás Pascual José Manuel Pérez-García

SEOM clinical guidelines on cardiovascular toxicity (2018)

2019 · Clinical & Translational Oncology · 33 citations

https://doi.org/10.1007/s12094-018-02017-3

Juan Antonio Virizuela Ana Martín‐Garcia R. de las Peñas Ana Santaballa

SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan

2015 · Supportive Care in Cancer · 12 citations

https://doi.org/10.1007/s00520-015-2948-6

R. de las Peñas Santiago Ponce Fernando Henao Carlos Camps

Research topics

topics

Bladder and Urothelial Cancer Treatments

Urinary and Genital Oncology Studies

Cancer Treatment and Pharmacology

Advanced Breast Cancer Therapies

Cancer Immunotherapy and Biomarkers

Chat about Author

Papers

Chat

Click to start Chat